Standard BioTools Inc. (LAB) vs Sagimet Biosciences Inc. (SGMT)
A side-by-side comparison of Standard BioTools Inc. and Sagimet Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LAB
Standard BioTools Inc.
$0.73HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
SGMT
Sagimet Biosciences Inc.
$8.78HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — LAB vs SGMT
growth of $100 · dividends reinvested · last 3yLAB -68.6% (-32.0%/yr)SGMT -43.4% (-17.3%/yr)SGMT compounded faster over this window
LAB SGMT
LAB vs SGMT: by the numbers
- •LAB is the larger company ($287M vs $286M market cap).
- •Both run net losses; SGMT's is the smaller (0.00% vs -103.29% net margin).
Metrics side by side
Valuation
| Metric | LAB | SGMT |
|---|---|---|
| P/S ratio | 3.39 | N/A |
| P/B ratio | 0.53 | 1.12 |
Profitability
| Metric | LAB | SGMT |
|---|---|---|
| Gross margin | 49.14% | 0.00% |
| Operating margin | -109.34% | 0.00% |
| Net margin | -103.29% | 0.00% |
| ROE | -16.18% | -18.38% |
| ROIC | -14.06% | -20.40% |
Growth (annualized)
| Metric | LAB | SGMT |
|---|---|---|
| Revenue CAGR (5Y) | -10.62% | N/A |
| Total return CAGR (5Y) | -32.98% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.